Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-κB

Infection and Immunity

Volumn 64, Issue 9, 1996, Pages 3845-3852

  Norgard, Michael V ^a   Arndt, Leslie L ^a   Akins, Darrin R ^a   Curetty, Linda L ^a   Harrich, David A ^a   Radolf, Justin D ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE;

ARTICLE; BORRELIA BURGDORFERI; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LYME DISEASE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; SYPHILIS; TRANSCRIPTION INITIATION; TREPONEMA PALLIDUM;

EID: 0029782133     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.9.3845-3852.1996     Document Type: Article

References (72)

1. Akins, D. R., S. F. Porcella, T. G. Popova, D. Shevchenko, M. Li, M. V. Norgard, and J. D. Radolf. 1995. Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue. Mol. Microbiol. 18:507-520.
2. Akins, D. R., B. K. Purcell, M. Mitra, M. V. Norgard, and J. D. Radolf. 1993. Lipid modification of the 17-kilodalton membrane immunogen of Treponema pallidum determines macrophage activation as well as amphiphilicity. Infect. Immun. 61:1202-1210.
3. Auwerx, J. 1991. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47:22-31.
4. Bachelerie, F., J. Alcami, F. Arenzana-Seisdedos, and J.-L. Virelizier. 1991. HIV enhancer activity perpetuated by NF-kappaB induction on infection of monocytes. Nature (London) 350:709-712.
5. Baldari, C., J. A. H. Murray, P. Ghiara, G. Cesareni, and C. L. Galeotti. 1987. A novel leader peptide which allows efficient secretion of a fragment of human interleukin 1β in Saccharomyces cerevisiae. EMBO J. 6:229-234.
6. Barbour, A. G. 1984. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57:521-525.
7. Bellsle, J. T., M. E. Brandt, J. D. Radolf, and M. V. Norgard. 1994. Fatty acids of Treponema pallidum and Borrelia burgdorferi lipoproteins. J. Bacteriol. 176:2151-2157.
8. Bergstrom, S., V. G. Bundoc, and A. G. Barbour. 1989. Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi. Mol. Microbiol. 3:479-486.
9. Bessler, W. G., M. Cox, A. Lex, B. Suhr, K.-H. Wiesmuller, and G. Jung. 1985. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes. J. Immunol. 135:1900-1905.
10. Brandt, M. E., B. S. Riley, J. D. Radolf, and M. V. Norgard. 1990. Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins. Infect. Immun. 58:983-991.
11. Chamberlain, N. R., M. E. Brandt, A. L. Erwin, J. D. Radolf, and M. V. Norgard. 1989. Major integral membrane protein immunogens of Treponema pallidum are proteolipids. Infect. Immun. 57:2872-2877.
12. Champion, C. I., D. R. Blanco, J. T. Skare, D. A. Haake, M. Giladi, D. Foley, J. N. Miller, and M. A. Lovett. 1994. A 9.0-kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection. Infect. Immun. 62:2653-2661.
13. Corradin, S. B., J. Manel, P. Gallay, D. Heumann, R. J. Ulevitch, and P. S. Tobias. 1992. Enhancement of murine macrophages binding of and response to bacterial lipopolysaccharide (LPS) by LPS-binding protein. J. Leukocyte Biol. 52:363-368.
14. DeOgny, L., B. C. Pramanik, L. L. Arndt, J. D. Jones, J. Rush, C. A. Slaughter, J. D. Radolf, and M. V. Norgard. 1994. Solid-phase synthesis of biologically active lipopeptides as analogs for spirochetal lipoproteins. Peptide Res. 7:91-97.
15. Dong, Z., X. Qi, and I. J. Fidler. 1993. Tyrosine phosphorylation of mitogen-activated protein kinases is necessary for activation of murine macrophages by natural and synthetic bacterial products. J. Exp. Med. 177:1071-1077.
16. Fauci, A. S., S. M. Schnittman, G. Poll, S. Koenig, and G. Pantaleo. 1991. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 114:678-693.
17. Folks, T. M., J. Justement, A. Kinter, C. Dinarello, and A. S. Fauci. 1987. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte line. Science 238:800-802.
18. Han, J., J.-D. Lee, L. Bibbs, and R. J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811.
19. Han, J., J.-D. Lee, P. S. Tobias, and R. J. Ulevitch. 1993. Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J. Biol. Chem. 268:25009-25014.
20. Hardy, P. H., Jr., and J. Levin. 1983. Lack of endotoxin in Borrelia hispanica and Treponema pallidum. Proc. Soc. Exp. Biol. Med. 174:47-52.
21. Harris, P., and P. Ralph. 1985. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J. Leukocyte Biol. 37:407-422.
22. Hauschildt, S., P. Hoffmann, H. U. Beuscher, G. Dufhues, P. Heinrich, K.-H. Wiesmuller, G. Jung, and W. G. Bessler. 1990. Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis, and Ia expression. Eur. J. Immunol. 20:63-68.
23. Haziot, A., E. Ferrero, F. Kontgen, M. Hijiya, S. Yamamoto, J. Silver, C. L. Stewart, and S. M. Goyert. 1996. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4:407-414.
24. Ho, D. D., T. R. Rota, and M. S. Hirsch. 1986. Infection of monocyte/ macrophages by human T lymphotrophic virus type III. J. Clin. Invest. 77:1712-1715.
25. Hoffmann, P., S. Heinle, U. F. Schade, H. Loppnow, A. J. Ulmer, H.-D. Flad, G. Jung, and W. G. Bessler. 1988. Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immunobiology 177:158-170.
26. Hook, E. W., III. 1989. Syphilis and HIV infection. J. Infect. Dis. 160:530-534.
27. Hutchinson, C. M., A. M. Rompalo, C. A. Reichart, and E. W. Hook. 1991. Characteristics of patients with syphilis attending Baltimore STD clinics: multiple high-risk subgroups and interactions with human immunodeficiency virus infection. Arch. Intern. Med. 151:511-516.
28. Jeerapaet, P., and A. B. Ackerman. 1973. Histologic patterns of secondary syphilis. Arch. Dermatol. 107:373-377.
29. Jones, J. D., K. W. Bourell, M. V. Norgard, and J. D. Radolf. 1995. Membrane topology of Borrelia burgdorferi and Treponema pallidum lipoproteins. Infect. Immun. 63:2424-2434.
30. Kirkland, T. N., G. D. Virca, T. Kuus Reichel, F. K. Muller, S. Y. Kim, R. J. Ulevitch, and P. S. Tobias. 1990. Identification of lipopolysaccharide-binding proteins in 70Z/3 cells by photoaffinity cross-linking. J. Biol. Chem. 265: 9520-9525.
31. Kitchens, R. L., R. J. Ulevitch, and R. S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176:485-494.
32. 3. Blood 76: 2457-2461.
33. Lee, J.-D., K. Kato, P. S. Tobias, T. N. Kirkland, and R. J. Ulevitch. 1992. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J. Exp. Med. 175:1697-1705.
34. Lenardo, M. J., and D. Baltimore. 1989. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227-229.
35. Lukehart, S. A., and K. K. Holmes. 1994. Syphilis, p. 726-737. In K. J. Isselbacher, E. Braunwald, J. Wilson, J. B. Martin, A. S. Fauci, and D. L. Kasper (ed.), Harrison's principles of internal medicine. McGraw-Hill. Inc., New York.
36. Ma, Y., K. P. Seiler, K.-F. Tai, L. Yang, M. Woods, and J. J. Weis. 1994. Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect. Immun. 62:3663-3671.
37. Ma, Y., and J. J. Weis. 1993. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect. Immun. 61:3843-3853.
38. Marra, C. M. 1992. Syphilis and human immunodeficiency virus infection. Semin. Neurol. 12:43-50.
39. Metzger, J. W., W. H. Sawyer, B. Wille, L. Biesert, W. G. Bessler, and G. Jung. 1993. Interaction of immunologically-active lipopeptides with membranes. Biochim. Biophys. Acta 1149:29-39.
40. Montgomery, R. R., S. E. Malawista, K. J. M. Feen, and L. K. Bockenstedt. 1996. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J. Exp. Med. 183:261-269.
41. Muller, J. M., H. W. L. Ziegler-Heitbrock, and P. A. Baeuerle. 1993. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187:233-256.
42. Nocton, J. J., and A. C. Steere. 1995. Lyme disease. Adv. Intern. Med. 40:69-115.
43. Norgard, M. V., B. S. Riley, J. A. Richardson, and J. D. Radolf. 1995. Dermal inflammation elicited by synthetic analogs of Treponema pallidum and Borrelia burgdorferi lipoproteins. Infect. Immun. 63:1507-1515.
44. Offermanns, S., R. Seifert, J. W. Metzger, G. Jung, A. Lieberknecht, U. Schmidt, and G. Schultz. 1992. Lipopeptides are effective stimulators of tyrosine phosphorylation in human myeloid cells. Biochem. J. 282:551-557.
45. Paige, C. J., P. W. Kincade, and P. Ralph. 1978. Murine B cell leukemia line with inducible surface immunoglobulin expression. J. Immunol. 121:641-647.
46. Pomerantz, R. J., M. B. Feinberg, D. Trono, and D. Baltimore. 1990. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J. Exp. Med. 172:253-261.
47. Pugin, J., D. Heumann, A. Tomasz, V. V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509-516.
48. Radolf, J. D., K. W. Bourell, D. R. Akins, J. S. Brusca, and M. V. Norgard. 1994. Analysis of Borrelia burgdorferi membrane architecture by freeze-fracture electron microscopy. J. Bacteriol. 176:21-31.
49. Radolf, J. D., and M. V. Norgard. 1988. Pathogen-specificity of integral membrane proteins of Treponema pallidum subsp. pallidum identified by phase partitioning with Triton X-114. Infect. Immun. 56:1825-1828.
50. Radolf, J. D., M. V. Norgard, M. E. Brandt, R. D. Isaacs, P. A. Thompson, and B. Beutler. 1991. Lipoproteins of Borrelia burgdorferi and Treponema patlidum activate cachectin/tumor necrosis factor synthesis: analysis using a CAT reporter construct. J. Immunol. 147:1968-1974.
51. Radolf, J. R., L. L. Arndt, D. R. Akins, L. L. Curetty, M. E. Levi, Y. Shen, L. S. Davis, and M. V. Norgard. 1995. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154:2866-2877.
52. Rawadi, G., and S. Roman-Roman. 1996. Mycoplasma membrane lipoproteins induce proinflammatory cytokines by a mechanism distinct from that of lipopolysaccharide. Infect. Immun. 64:637-643.
53. Riley, B. S., N. Oppenheimer-Marks, E. J. Hansen, J. D. Radolf, and M. V. Norgard. 1992. Virulent Treponema pallidum activates human vascular endothelial cells. J. Infect. Dis. 165:484-493.
54. Roulston, A., R. Lin, P. Beauparlant, M. A. Wainberg, and J. Hiscott. 1995. Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-κB/Rel transcription factors. Microbiol. Rev. 59:481-505.
55. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
56. Schouls, L. M., R. Mout, J. Dekker, and J. D. A. Van Embden. 1989. Characterization of lipid-modified immunogenic proteins of Treponema pallidum expressed in Escherichia coli. Microb. Pathog. 7:175-188.
57. Schwan, T. G., J. Piesman, W. T. Golde, M. C. Dolan, and P. A. Rosa. 1995. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. USA 92:2909-2913.
58. Sellati, T. J., L. D. Abrescia, J. D. Radolf, and M. B. Furie. 1996. Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro. Infect. Immun. 64:3180-3187.
59. Sibley, C. H., A. Terry, and C. R. H. Raetz. 1988. Induction of kappa light chain synthesis in 70Z/3 B lymphoma cells by chemically defined lipid A precursors. J. Biol. Chem. 263:5098-5103.
60. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
61. Stamm, W. E., H. H. Handsfield, A. M. Rompalo, R. L. Ashley, P. L. Roberts, and L. Corey. 1988. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 260:1429-1433.
62. Stevenson, B., T. G. Schwan, and P. A. Rosa. 1995. Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 63:4535-4539.
63. Tai, K.-F., Y. Ma, and J. J. Weis. 1994. Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA. Infect. Immun. 62:520-528.
64. Takayama, K., R. J. Rothenberg, and A. G. Barbour. 1987. Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 55:2311-2313.
65. Tatro, J. B., L. I. Romero, D. Beasley, A. C. Steere, and S. Reichlin. 1994. Borrelia burgdorferi and Escherichia coli lipopolysaccharides induce nitric oxide and interleukin-6 production in cultured rat brain cells. J. Infect. Dis. 169:1014-1022.
66. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26:171-176.
67. Ulevitch, R. J., and P. S. Tobias. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437-457.
68. Wallach, R., C. Brenner, M. D. Kramer, and M. M. Simon. 1995. Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene,pG, of Borrelia burgdorferi expressed only in vivo. Infect. Immun. 63:3327-3335.
69. Wasserheit, J. N. 1992. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex. Transm. Dis. 19:61-77.
70. Weigel, L. M., M. E. Brandt, and M. V. Norgard. 1992. Analysis of the N-terminal region of the 47-kilodalton integral membrane lipoprotein of Treponema pallidum. Infect. Immun. 60:1568-1576.
71. Weis, J. J., Y. Ma, and L. F. Erdile. 1994. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect. Immun. 62:4632-4636.
72. Yun Tso, J., X.-H. Sun, T. Kao, K. S. Reece, and R. Wu. 1985. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:2485-2502.